$0.4904
At close: Apr 7, 7:30 PM EDT
$0.5248
0.037.01%
After Hours: 7:30 PM EDT
Comments
Loading...
Nektar Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:NKTR | Benzinga
Nektar Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.180
Quarterly Revenue Estimate
$15.61M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$98.43M
Analyze the earnings history of Nektar Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | -$0.19 | -$0.18 | — | — | $21.64M | $15.61M | — | — | 05/08/2025 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.22 | -$0.19 | -$0.15 | 21.05% | $23.89M | $36.66M | $29.18M | -20.42% | 03/12/2025 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.19 | -$0.21 | -$0.18 | 14.29% | $24.14M | $18.28M | $24.12M | 31.97% | 11/07/2024 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.27 | -$0.20 | -$0.25 | -25.00% | $20.50M | $17.54M | $23.49M | 33.92% | 08/08/2024 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.25 | -$0.19 | -$0.19 | 0.00% | $21.59M | $15.34M | $21.64M | 41.06% | 05/09/2024 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.32 | -$0.21 | -$0.22 | -4.76% | $22.02M | $18.05M | $23.89M | 32.33% | 03/04/2024 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.31 | -$0.20 | -$0.19 | 5.00% | $23.63M | $21.31M | $24.14M | 13.30% | 11/07/2023 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.85 | -$0.28 | -$0.27 | 3.57% | $21.59M | $21.83M | $20.50M | -6.10% | 08/08/2023 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.49 | -$0.25 | -$0.25 | 0.00% | $24.82M | $19.84M | $21.59M | 8.84% | 05/09/2023 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.79 | -$0.45 | -$0.32 | 28.89% | $25.01M | $22.13M | $22.02M | -0.48% | 02/28/2023 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.70 | -$0.45 | -$0.31 | 31.11% | $24.92M | $22.61M | $23.63M | 4.49% | 11/03/2022 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.69 | -$0.94 | -$0.85 | 9.57% | $28.33M | $22.66M | $21.59M | -4.74% | 08/04/2022 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.68 | -$0.68 | -$0.49 | 27.94% | $23.65M | $24.38M | $24.82M | 1.81% | 05/05/2022 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.65 | -$0.81 | -$0.79 | 2.47% | $23.46M | $25.33M | $25.01M | -1.27% | 02/28/2022 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.61 | -$0.80 | -$0.70 | 12.50% | $30.03M | $27.87M | $24.92M | -10.58% | 11/04/2021 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.45 | -$0.74 | -$0.69 | 6.76% | $48.85M | $25.98M | $28.33M | 9.05% | 08/05/2021 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.53 | -$0.72 | -$0.68 | 5.56% | $50.57M | $26.90M | $23.65M | -12.09% | 05/06/2021 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.64 | -$0.68 | -$0.65 | 4.41% | $33.86M | $30.01M | $23.46M | -21.82% | 02/25/2021 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.56 | -$0.74 | -$0.61 | 17.57% | $29.22M | $26.33M | $30.03M | 14.06% | 11/05/2020 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.63 | -$0.68 | -$0.45 | 33.82% | $23.32M | $22.80M | $48.85M | 114.24% | 08/06/2020 | Get Alert |
| NKTR | Nektar Therapeutics | -$0.68 | -$0.71 | -$0.53 | 25.35% | $28.22M | $47.64M | $50.57M | 6.16% | 05/07/2020 | Get Alert |
Nektar Therapeutics (NKTR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-12 | $-0.15 | $-0.19 | 21.1 % |
| Q3 | 2024-11-07 | $-0.18 | $-0.21 | 14.3 % |
| Q2 | 2024-08-08 | $-0.25 | $-0.20 | -25.0 % |
| Q1 | 2024-05-09 | $-0.19 | $-0.19 | 0.00 % |
Nektar Therapeutics (NKTR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-12 | $29.18M | $36.66M | -20.4 % |
| Q3 | 2024-11-07 | $24.12M | $18.28M | 32.0 % |
| Q2 | 2024-08-08 | $23.49M | $17.54M | 33.9 % |
| Q1 | 2024-05-09 | $21.64M | $15.34M | 41.1 % |
FAQ
When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?
Nektar Therapeutics (NKTR) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 12, 2025 for Q4.
What were the latest earnings per share (EPS) for Nektar Therapeutics (NASDAQ:NKTR)?
The Actual EPS was $-0.15, which beat the estimate of $-0.19.
What were Nektar Therapeutics’s (NASDAQ:NKTR) revenues?
The Actual Revenue was $29.2M, which missed the estimate of $36.7M.
Browse earnings estimates, EPS, and revenue on all stocks.